Clarus licenses rights to McGill technology to treat conditions associated with CoQ10 deficiencies Sep. 17, 2021
Targeting RON short form suppresses breast cancer metastasis through subverted immunosuppression Sep. 17, 2021
Tarveda and SciClone enter license agreement for preclinical PI3K miniature drug conjugates Sep. 17, 2021
Endeavor BioMedicines licenses rights to ULK1/2 inhibitor for LKB1- and RAS-mutated cancers Sep. 17, 2021
RSS